KindlyMD (NAKA) Competitors $1.13 +0.03 (+2.73%) As of 10/3/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock NAKA vs. PGNY, NHC, ARDT, AVAH, GRAL, VRDN, TDOC, OMDA, AHCO, and FTREShould you be buying KindlyMD stock or one of its competitors? The main competitors of KindlyMD include Progyny (PGNY), National HealthCare (NHC), Ardent Health (ARDT), Aveanna Healthcare (AVAH), GRAIL (GRAL), Viridian Therapeutics (VRDN), Teladoc Health (TDOC), Omada Health (OMDA), AdaptHealth (AHCO), and Fortrea (FTRE). These companies are all part of the "healthcare" industry. KindlyMD vs. Its Competitors Progyny National HealthCare Ardent Health Aveanna Healthcare GRAIL Viridian Therapeutics Teladoc Health Omada Health AdaptHealth Fortrea KindlyMD (NASDAQ:NAKA) and Progyny (NASDAQ:PGNY) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership. Which has more risk & volatility, NAKA or PGNY? KindlyMD has a beta of 31.1, indicating that its share price is 3,010% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500. Do insiders and institutionals hold more shares of NAKA or PGNY? 94.9% of Progyny shares are owned by institutional investors. 40.8% of KindlyMD shares are owned by insiders. Comparatively, 9.4% of Progyny shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts prefer NAKA or PGNY? KindlyMD presently has a consensus target price of $8.00, suggesting a potential upside of 607.96%. Progyny has a consensus target price of $25.44, suggesting a potential upside of 23.58%. Given KindlyMD's higher possible upside, analysts clearly believe KindlyMD is more favorable than Progyny.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KindlyMD 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Progyny 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.70 Is NAKA or PGNY more profitable? Progyny has a net margin of 4.28% compared to KindlyMD's net margin of -244.00%. Progyny's return on equity of 10.69% beat KindlyMD's return on equity.Company Net Margins Return on Equity Return on Assets KindlyMD-244.00% -131.09% -106.04% Progyny 4.28%10.69%7.12% Does the media favor NAKA or PGNY? In the previous week, Progyny had 2 more articles in the media than KindlyMD. MarketBeat recorded 4 mentions for Progyny and 2 mentions for KindlyMD. Progyny's average media sentiment score of 0.71 beat KindlyMD's score of 0.32 indicating that Progyny is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Progyny 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, NAKA or PGNY? Progyny has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKindlyMD$2.72M171.83-$3.62M-$0.86-1.31Progyny$1.17B1.52$54.34M$0.5934.90 SummaryProgyny beats KindlyMD on 13 of the 17 factors compared between the two stocks. Get KindlyMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NAKA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAKA vs. The Competition Export to ExcelMetricKindlyMDMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$467.37M$8.23B$6.13B$10.58BDividend YieldN/A2.80%5.67%4.69%P/E Ratio-1.3175.2686.9626.71Price / Sales171.8340.93605.32131.81Price / CashN/A23.0137.9061.31Price / Book2.636.7612.556.55Net Income-$3.62M$250.93M$3.31B$277.50M7 Day Performance-1.74%2.29%4.28%2.42%1 Month Performance-72.30%3.27%6.90%8.63%1 Year PerformanceN/A10.51%70.54%31.60% KindlyMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAKAKindlyMD2.138 of 5 stars$1.13+2.7%$8.00+608.0%N/A$467.37M$2.72M-1.31N/AShort Interest ↑PGNYProgyny3.9293 of 5 stars$21.47-3.0%$25.44+18.5%+26.3%$1.90B$1.17B36.39310NHCNational HealthCareN/A$122.75+0.4%N/A-1.4%$1.90B$1.46B15.3812,400Positive NewsEx-DividendARDTArdent Health3.9485 of 5 stars$13.22+1.4%$19.33+46.2%-22.3%$1.86B$5.97B7.3024,900Positive NewsAVAHAveanna Healthcare1.0032 of 5 stars$8.39-0.1%$7.92-5.6%+90.5%$1.75B$2.02B104.8833,500GRALGRAIL1.2217 of 5 stars$46.98+5.6%$31.50-33.0%+403.0%$1.60B$125.60M-3.581,360News CoverageAnalyst ForecastInsider TradeGap UpVRDNViridian Therapeutics1.9625 of 5 stars$19.56+0.1%$37.78+93.1%-9.5%$1.60B$300K-5.1150Positive NewsTDOCTeladoc Health1.6729 of 5 stars$8.39+2.4%$9.80+16.8%-0.4%$1.45B$2.57B-7.055,500News CoverageHigh Trading VolumeOMDAOmada HealthN/A$23.44+0.5%$24.50+4.5%N/A$1.34B$209.83M0.00849AHCOAdaptHealth3.9256 of 5 stars$8.97+1.4%$13.40+49.4%-12.9%$1.20B$3.26B16.6110,500News CoveragePositive NewsAnalyst UpgradeFTREFortrea3.2742 of 5 stars$9.37-2.8%$11.50+22.7%-49.7%$875.31M$2.70B-0.8215,500Analyst Forecast Related Companies and Tools Related Companies Progyny Alternatives National HealthCare Alternatives Ardent Health Alternatives Aveanna Healthcare Alternatives GRAIL Alternatives Viridian Therapeutics Alternatives Teladoc Health Alternatives Omada Health Alternatives AdaptHealth Alternatives Fortrea Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAKA) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KindlyMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KindlyMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAKA Stock Alerts